EN
HI
Akums Drugs & Pharmaceuticals Share Price
AKUMS
7133.15 (-0.44%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 20 Nov, 2026, Akums Drugs & Pharmaceuticals stock price is ₹713. During the trading session, the stock has moved between an intraday low of ₹702.65 and an intraday high of ₹717.05. Over the last 52 weeks, Akums Drugs & Pharmaceuticals has traded between ₹409.30 and ₹838.80.
The stock has recorded a trading volume of 75,490 shares,. Its Average Traded Price (ATP) is ₹711.25, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹713.00.
Akums Drugs & Pharmaceuticals has an upper circuit limit of ₹787.75 and a lower circuit limit of ₹644.55. The total value traded stands at ₹5.37 CR, and the delivery percentage for the day is 47.57%.
The stock is currently traded with a market lot size of 1. Akums Drugs & Pharmaceuticals also offers a dividend yield of 0.42%.
Akums Drugs & Pharmaceuticals Share Price Chart
Akums Drugs & Pharmaceuticals Share Key Metrics
Volume
75490.00
Market Cap
11219.83 CR
LTQ@LTP
6@713.00
ATP
711.25
Var Margin
17.4 %
Circuit Range
644.55-787.75
Delivery %
47.57 %
Value
5.37 CR
ASM/GSM
No
Market Lot
1
Akums Drugs & Pharmaceuticals Resistance and Support
Pivot 716.95
Resistance
First Resistance
723.2
Second Resistance
730.25
Third Resistance
736.5
Support
First Support
709.9
Second Support
703.65
Third Support
696.6
Akums Drugs & Pharmaceuticals Shareholding Pattern
View More- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
75.26%
Mutual Fund
7.58%
Insurance
0.12%
Foreign Institutional Investors
4.5%
Domestic Institutional Investors
3.38%
Retail
9.16%
Others
0%
Total Promoters
MAR '26
75.26%
JUN '26
75.26%
SEP '26
75.26%
Akums Drugs & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-08-08 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-24 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-03 | 2026-07-03 | View More |
Akums Drugs & Pharmaceuticals News
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Akums Drugs & Pharma reported a strong Q2 FY27 with cons. revenue of Rs.1,342 crore, up 31.9% YoY, and net profit of Rs.115 crore, up 168% YoY. Through its subsidiary, the company acquired Oriflame India's manufacturing business for Rs.56 crore.
Nov 02 2026 18:04:32
Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Intimation for Intimation Of Board Meeting
Akums Drugs & Pharma board to meet on 02 Nov 2026 for financial results. The meeting will cover the quarter and half-year ended 30 Sep 2026.
Oct 28 2026 15:41:11
Akums Drugs & Pharmaceuticals Management
| Name | Position |
|---|---|
| Sanjeev Jain | Managing Director |
| Sandeep Jain | Managing Director |
Akums Drugs & Pharmaceuticals Similar Stocks
Rainbow Children's Medicare Ltd.
1245.00
-13.00 (1.03%)
Alivus Life Sciences Ltd.
1449.90
5.20 (0.36%)
Metropolis Healthcare Ltd.
561.50
-2.80 (0.50%)
Concord Biotech Ltd.
556.30
-4.70 (0.84%)
Sanofi Consumer Healthcare India Ltd.
3498.20
-34.10 (0.97%)
Yatharth Hospital & Trauma Care Services Ltd.
1085.00
-6.10 (0.56%)
Viyash Scientific Ltd.
235.84
0.23 (0.10%)
Park Medi World Ltd.
238.73
0.69 (0.29%)
Symbiotec Pharmalab Ltd.
1604.80
-16.50 (1.02%)
Blue Jet Healthcare Ltd.
516.85
-1.60 (0.31%)
Akums Drugs & Pharmaceuticals FAQs
The Buying Price of Akums Drugs & Pharmaceuticals share is 713 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 31. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 3.22. Useful to assess the stock's value relative to its book value.
To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.25 & 2.53 with sector averages, along with growth rates and financial metrics.
The Market Cap of Akums Drugs & Pharmaceuticals is 11219.83 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 838.80 & 409.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AKUMS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC